Description
Book SynopsisThis book examines how government, industry and society interact to reach a level of regulation that is deemed satisfactory for the newly-emerged transformative technology that is agricultural biotechnology. It considers issues of risk and trust surrounding genetically modified plants for the production of food and pharmaceuticals. It describes how regulations have been produced to manage, or in some cases ignore, the risks from GM products. The scope is international and the book makes a significant contribution to the literature in this growing field of interest.
Table of ContentsPART I: INTRODUCTION 1: Liability and Transformative Technology PART II: DIAGNOSIS 2: Innovation and Liability 3: Social Amplification of Risk 4: Consumer Responses to GM Foods PART III: CURRENT PRESCRIPTIONS 5: Regulating Transformative Technologies 6: International Governance of Liabilities 7: Biological Mechanisms to Control GM Liabilities 8: Supply Chain Responses to Liability 9: Product Differentiation Strategies PART IV: PROGNOSIS 10: Liability of Plant Made Pharmaceuticals 11: Handling Liabilities from Transformative Technologies
